HIK.L
HIK.L
GB00B0LCW083
HIKMA PHARMACEUTICALS PLC ORD S
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 3.349.000.000 3.127.000.000
7.1%
Cost of Revenue 1.908.000.000 1.712.000.000
11.4%
Gross Profit 1.441.000.000 1.415.000.000
1.8%
808.000.000 803.000.000
0.6%
Operating Income 633.000.000 612.000.000
3.4%
Pretax Income 519.000.000 455.000.000
14.1%
Net Income Common Stockholders 402.000.000 359.000.000
12.0%
-- --
--
-- --
--
ende